476 related articles for article (PubMed ID: 17894848)
1. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.
Hamaguchi M; Kojima T; Itoh Y; Harano Y; Fujii K; Nakajima T; Kato T; Takeda N; Okuda J; Ida K; Kawahito Y; Yoshikawa T; Okanoue T
Am J Gastroenterol; 2007 Dec; 102(12):2708-15. PubMed ID: 17894848
[TBL] [Abstract][Full Text] [Related]
2. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD).
Mishra P; Younossi ZM
Am J Gastroenterol; 2007 Dec; 102(12):2716-7. PubMed ID: 18042105
[TBL] [Abstract][Full Text] [Related]
3. [Ultrasonography in the diagnosis of nonalcoholic fatty liver disease].
Gomercić M; Duvnjak M; Barsić N
Acta Med Croatica; 2009 Dec; 63 Suppl 3():1-3. PubMed ID: 20235368
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.
Lazo M; Hernaez R; Eberhardt MS; Bonekamp S; Kamel I; Guallar E; Koteish A; Brancati FL; Clark JM
Am J Epidemiol; 2013 Jul; 178(1):38-45. PubMed ID: 23703888
[TBL] [Abstract][Full Text] [Related]
5. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.
Hamaguchi M; Takeda N; Kojima T; Ohbora A; Kato T; Sarui H; Fukui M; Nagata C; Takeda J
World J Gastroenterol; 2012 Apr; 18(13):1508-16. PubMed ID: 22509083
[TBL] [Abstract][Full Text] [Related]
6. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study.
Dasarathy S; Dasarathy J; Khiyami A; Joseph R; Lopez R; McCullough AJ
J Hepatol; 2009 Dec; 51(6):1061-7. PubMed ID: 19846234
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
Schwenzer NF; Springer F; Schraml C; Stefan N; Machann J; Schick F
J Hepatol; 2009 Sep; 51(3):433-45. PubMed ID: 19604596
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.
Ballestri S; Lonardo A; Romagnoli D; Carulli L; Losi L; Day CP; Loria P
Liver Int; 2012 Sep; 32(8):1242-52. PubMed ID: 22520641
[TBL] [Abstract][Full Text] [Related]
9. The global NAFLD epidemic.
Loomba R; Sanyal AJ
Nat Rev Gastroenterol Hepatol; 2013 Nov; 10(11):686-90. PubMed ID: 24042449
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.
Lee JH; Kim D; Kim HJ; Lee CH; Yang JI; Kim W; Kim YJ; Yoon JH; Cho SH; Sung MW; Lee HS
Dig Liver Dis; 2010 Jul; 42(7):503-8. PubMed ID: 19766548
[TBL] [Abstract][Full Text] [Related]
11. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Vernon G; Baranova A; Younossi ZM
Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.
Hernaez R; Lazo M; Bonekamp S; Kamel I; Brancati FL; Guallar E; Clark JM
Hepatology; 2011 Sep; 54(3):1082-1090. PubMed ID: 21618575
[TBL] [Abstract][Full Text] [Related]
13. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
; ;
J Hepatol; 2016 Jun; 64(6):1388-402. PubMed ID: 27062661
[No Abstract] [Full Text] [Related]
14. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.
Brunt EM; Kleiner DE; Wilson LA; Belt P; Neuschwander-Tetri BA;
Hepatology; 2011 Mar; 53(3):810-20. PubMed ID: 21319198
[TBL] [Abstract][Full Text] [Related]
15. Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.
Lee YS; Kek BL; Poh LK; Saw SM; Loke KY
J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):172-8. PubMed ID: 18664869
[TBL] [Abstract][Full Text] [Related]
16. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
[No Abstract] [Full Text] [Related]
18. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Hepatology; 2011 Jun; 53(6):1883-94. PubMed ID: 21381068
[TBL] [Abstract][Full Text] [Related]
19. Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis.
Xu R; Tao A; Zhang S; Deng Y; Chen G
Sci Rep; 2015 Mar; 5():9284. PubMed ID: 25791171
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
Romeo S; Kozlitina J; Xing C; Pertsemlidis A; Cox D; Pennacchio LA; Boerwinkle E; Cohen JC; Hobbs HH
Nat Genet; 2008 Dec; 40(12):1461-5. PubMed ID: 18820647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
